Jasper Therapeutics Inc. (JSPRW)
0.13
-0.04 (-23.35%)
At close: Jan 15, 2025, 3:43 PM
0.15
19.99%
After-hours Jan 15, 2025, 03:44 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -64.47M | -37.69M | -30.64M | -31.67M | -4.99M |
| Depreciation & Amortization | 1.11M | 975.00K | 377.00K | 21.00K | n/a |
| Stock-Based Compensation | 5.21M | 4.09M | 1.05M | 1.21M | 6.00K |
| Other Working Capital | 2.06M | 1.50M | -1.32M | 938.00K | 1.39M |
| Other Non-Cash Items | 976.00K | -12.59M | -9.09M | 10.90M | 1.62M |
| Deferred Income Tax | n/a | n/a | 3.00M | -21.00K | n/a |
| Change in Working Capital | 5.10M | -649.00K | 1.62M | 1.30M | 1.39M |
| Operating Cash Flow | -52.07M | -45.86M | -33.68M | -18.27M | -1.97M |
| Capital Expenditures | -267.00K | -576.00K | -2.43M | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | 198.34K | n/a |
| Investing Cash Flow | -267.00K | -576.00K | -2.43M | 198.34K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | 1.50M |
| Common Stock Repurchased | n/a | 28.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -56.00K | 55.00K | 100.97M | 11.29M | 27.63M |
| Financial Cash Flow | 100.97M | 55.00K | 100.97M | 11.29M | 29.13M |
| Net Cash Flow | 48.64M | -46.38M | 64.86M | -6.98M | 27.16M |
| Free Cash Flow | -52.33M | -46.43M | -36.11M | -18.27M | -1.97M |